117 related articles for article (PubMed ID: 21784858)
1. Adiponectin ameliorates doxorubicin-induced cardiotoxicity through Akt protein-dependent mechanism.
Maruyama S; Shibata R; Ohashi K; Ohashi T; Daida H; Walsh K; Murohara T; Ouchi N
J Biol Chem; 2011 Sep; 286(37):32790-800. PubMed ID: 21784858
[TBL] [Abstract][Full Text] [Related]
2. Focal adhesion kinase antagonizes doxorubicin cardiotoxicity via p21(Cip1.).
Cheng Z; DiMichele LA; Rojas M; Vaziri C; Mack CP; Taylor JM
J Mol Cell Cardiol; 2014 Feb; 67():1-11. PubMed ID: 24342076
[TBL] [Abstract][Full Text] [Related]
3. Everolimus prevents doxorubicin-induced apoptosis in H9c2 cardiomyocytes but not in MCF-7 cancer cells: Cardioprotective roles of autophagy, mitophagy, and AKT.
Kanno SI; Hara A
Toxicol In Vitro; 2023 Dec; 93():105698. PubMed ID: 37739323
[TBL] [Abstract][Full Text] [Related]
4. Ginkgolide B Exerts Cardioprotective Properties against Doxorubicin-Induced Cardiotoxicity by Regulating Reactive Oxygen Species, Akt and Calcium Signaling Pathways In Vitro and In Vivo.
Gao J; Chen T; Zhao D; Zheng J; Liu Z
PLoS One; 2016; 11(12):e0168219. PubMed ID: 27973574
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of ErbB2 by receptor tyrosine kinase inhibitors causes myofibrillar structural damage without cell death in adult rat cardiomyocytes.
Pentassuglia L; Graf M; Lane H; Kuramochi Y; Cote G; Timolati F; Sawyer DB; Zuppinger C; Suter TM
Exp Cell Res; 2009 Apr; 315(7):1302-12. PubMed ID: 19331811
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin promotes revascularization of ischemic muscle through a cyclooxygenase 2-dependent mechanism.
Ohashi K; Ouchi N; Sato K; Higuchi A; Ishikawa TO; Herschman HR; Kihara S; Walsh K
Mol Cell Biol; 2009 Jul; 29(13):3487-99. PubMed ID: 19398582
[TBL] [Abstract][Full Text] [Related]
7. Ischemia-induced cardiac dysfunction is exacerbated in adiponectin-knockout mice due to impaired autophagy flux.
Sung HK; Tang J; Jahng JWS; Song E; Chan YK; Lone AH; Peterson J; Abdul-Sater A; Sweeney G
Clin Transl Sci; 2024 Mar; 17(3):e13758. PubMed ID: 38515365
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies.
Takemura Y; Ouchi N; Shibata R; Aprahamian T; Kirber MT; Summer RS; Kihara S; Walsh K
J Clin Invest; 2007 Feb; 117(2):375-86. PubMed ID: 17256056
[TBL] [Abstract][Full Text] [Related]
9. NADPH oxidase 2 mediates cardiac sympathetic denervation and myocyte autophagy, resulting in cardiac atrophy and dysfunction in doxorubicin-induced cardiomyopathy.
Ma Y; Zhao HP; Yang LG; Li L; Wang AL; Zhang XJ; Wang K; Yang B; Zhu ZF; Zhang PJ; Wang JP; Chi RF; Li B; Qin FZ; Wang ZP
Sci Rep; 2024 Mar; 14(1):6971. PubMed ID: 38521855
[TBL] [Abstract][Full Text] [Related]
10. Phenyl-2-aminoethyl selenide ameliorates hippocampal long-term potentiation and cognitive deficits following doxorubicin treatment.
Alhowail AH; Eggert M; Bloemer J; Pinky PD; Woodie L; Bhattacharya S; Bhattacharya D; Buabeid MA; Smith B; Dhanasekaran M; Piazza G; Reed MN; Escobar M; Arnold RD; Suppiramaniam V
PLoS One; 2023; 18(11):e0294280. PubMed ID: 37948406
[TBL] [Abstract][Full Text] [Related]
11.
El-Said KS; Haidyrah AS; Mobasher MA; Khayyat AIA; Shakoori A; Al-Sowayan NS; Barnawi IO; Mariah RA
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958509
[TBL] [Abstract][Full Text] [Related]
12. Myocardial AKT: the omnipresent nexus.
Sussman MA; Völkers M; Fischer K; Bailey B; Cottage CT; Din S; Gude N; Avitabile D; Alvarez R; Sundararaman B; Quijada P; Mason M; Konstandin MH; Malhowski A; Cheng Z; Khan M; McGregor M
Physiol Rev; 2011 Jul; 91(3):1023-70. PubMed ID: 21742795
[TBL] [Abstract][Full Text] [Related]
13. AMPK as a mediator of tissue preservation: time for a shift in dogma?
Langer HT; Rohm M; Goncalves MD; Sylow L
Nat Rev Endocrinol; 2024 May; ():. PubMed ID: 38760482
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-induced cardiotoxicity and risk factors.
Belger C; Abrahams C; Imamdin A; Lecour S
Int J Cardiol Heart Vasc; 2024 Feb; 50():101332. PubMed ID: 38222069
[TBL] [Abstract][Full Text] [Related]
15. Complement 1q/Tumor Necrosis Factor-Related Proteins (CTRPs): Structure, Receptors and Signaling.
Schanbacher C; Hermanns HM; Lorenz K; Wajant H; Lang I
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831095
[TBL] [Abstract][Full Text] [Related]
16. Risk factors from Framingham risk score for anthracyclines cardiotoxicity in breast cancer: A systematic review and meta-analysis.
Jin H; Xu J; Sui Z; Wang L
Front Cardiovasc Med; 2023; 10():1101585. PubMed ID: 36742068
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs in doxorubicin-induced cardiotoxicity: The DNA damage response.
Kawano I; Adamcova M
Front Pharmacol; 2022; 13():1055911. PubMed ID: 36479202
[TBL] [Abstract][Full Text] [Related]
18. Mulberrin Confers Protection against Doxorubicin-Induced Cardiotoxicity via Regulating AKT Signaling Pathways in Mice.
Ye P; Li WL; Bao LT; Ke W
Oxid Med Cell Longev; 2022; 2022():2967142. PubMed ID: 35847586
[TBL] [Abstract][Full Text] [Related]
19. Incidence of trastuzumab-induced cardiotoxicity and impact of body mass index in patients with breast cancer: Results from a Saudi tertiary cancer center.
Al-Saleh K; Abdel-Warith A; Alghamdi M; Aldiab A; Ali A; Alsaeed EF; Abozeed WN; Abdel-Aziz N
Mol Clin Oncol; 2022 Apr; 16(4):78. PubMed ID: 35251629
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Targets for DOX-Induced Cardiomyopathy: Role of Apoptosis vs. Ferroptosis.
Kitakata H; Endo J; Ikura H; Moriyama H; Shirakawa K; Katsumata Y; Sano M
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
